UK and US risk factors for hearing loss in neonatal intensive care unit infants

Sally K Thornton1,2, Derek J Hoare1,2, Alice M Yates1

  • 1Hearing Sciences, Mental Health and Clinical Neurosciences, School of Medicine, The University of Nottingham, Nottingham, United Kingdom.

Plos One
|July 24, 2024
PubMed

Insights

Neonatal intensive care unit (NICU) admission increases congenital hearing loss risk. UK risk factors are specific but not sensitive; US factors are sensitive but not specific, necessitating further research for optimal surveillance.

Area of Science:

  • Neonatal care
  • Pediatric audiology
  • Congenital disorders

Background:

  • Early detection of hearing loss in infants is crucial for development.
  • Infants admitted to the neonatal intensive care unit (NICU) are at higher risk for hearing loss.
  • Identifying risk factors is vital for effective hearing loss surveillance in high-risk neonates.

Purpose of the Study:

  • To evaluate the effectiveness of current UK and US risk factors in identifying congenital hearing loss in infants with NICU admission.
  • To compare the sensitivity and specificity of UK and US hearing loss risk factors in a matched cohort.

Main Methods:

  • Retrospective cohort study of 142 inborn infants admitted to a tertiary NICU.
  • Matched 71 infants with permanent congenital hearing loss to 71 controls based on gestational age, birthweight, and sex.
  • Collected data on neonatal indicators and presence of UK and US risk factors for hearing loss.

Main Results:

  • 21% of infants with hearing loss had UK risk factors; 86% had US risk factors.
  • UK risk factors were highly specific but not sensitive for hearing loss.
  • US risk factors were sensitive but not specific, leading to potential false positives.

Conclusions:

  • Current UK and US risk factors have limitations in identifying all infants with congenital hearing loss.
  • UK factors are precise but miss cases; US factors identify more cases but include false positives.
  • Further national studies are needed to develop a combination of risk factors with high sensitivity and specificity for neonatal hearing loss surveillance.
Abstract